Revenue & Margin ImprovementSustained 20.8% revenue growth alongside rising gross and net margins signals stronger demand and a healthier product mix in specialty intermediates. These durable improvements support better cash generation and reinvestment capacity, strengthening the business over the medium term.
Conservative Balance SheetVery low leverage and a high equity ratio provide long-term financial flexibility and resilience to cyclicality in chemical markets. This conservative capital structure lowers default risk, preserves capacity to fund capex or acquisitions, and supports strategic optionality over months to years.
Improved Cash ConversionA recovery to positive free cash flow and strong operating cash conversion enhance liquidity and funding for operations, capex and shareholder returns. Durable cash-generation capability reduces reliance on external financing and improves ability to weather market swings.